The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.

Digital and DCT elements like eCOA, platforms, and wearables have transformed the ways we conduct clinical research. Read through the latest industry analysis and data on the real impacts these technologies have on clinical trials with this new ebook.

If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?

Digital and DCT elements like eCOA, platforms, and wearables have transformed the ways we conduct clinical research. Read through the latest industry analysis and data on the real impacts these technologies have on clinical trials with this new ebook.

Master protocol design trials require an endless stream of consent forms, adding time, cost, and risk. Learn how a feature-rich eConsent platform can simplify those processes and improve engagement.

Explore why the integration of etechnologies is critical in the modernization and optimization of clinical trials, and how the right partner will ensure studies are more efficient, reliable, and inclusive.

The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.

Recent research from the Tufts Center for the Study of Drug Development (CSDD) illuminated the substantial ROI of digital endpoints in clinical trials. Discover how to transform your trials today.

Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.